|Edgar Wingender started his career with an education as chemist and was trained as biochemist at the Technical University of Braunschweig, Germany. After 17 years of experimental work in different areas of molecular biology, mostly gene regulation problems, he fully dedicated himself to bioinformatics since 1993 when he was heading the research group Bioinformatics at the former German Research Centre for Biotechnology (GBF), now Helmholtz Center for Infection Research (HZI), in Braunschweig, Germany. He was coordinator of one of first eight research clusters funded by the German Ministry of Research and Technology. One of the major achievements of these early days was the TRANSFAC database on transcriptional regulation. Since then, he participated in and coordinated a number of national and international research consortia. In 1997, he founded the company BIOBASE together with H. Karas, I. Reuter and T. Heinemeyer. He was heading BIOBASE as President and CSO from January 2001 to January 2010. In 2002, he accepted a call from the University Medical Center of Georg August University in Goettingen, Germany, where he is now professor and director of the Institute of Bioinformatics. E. Wingender is also concurrent professor at Nanjing University, and founder and editor-in-chief of the journal In Silico Biology.
Presently, Edgar Wingender is the CEO of geneXplain GmbH.
Feel free to have a look at Dr. Wingender’s personal web page with a more detailed explanation of all projects he has been running so far, and a comprehensive list of his more than 140 publications. There is also a brief cv in Wikipedia (German only). More about his publication profile can be found here (MS Academic Search).
|Alexander Kel received his Ph.D. in Bioinformatics, Molecular Biology and Genetics in 1990. He studied biology and mathematics at Novosibirsk State University and obtained his M.S. in biology with special focus on mathematical biology in 1985. He worked for 15 years at the Institute of Cytology and Genetics, Russia (ICG) holding positions as a programmer, scientist, senior scientist and Vice-Head of the Laboratory of Theoretical Molecular Genetics. In 1995, he won the Academician Belaev Award. In 1999 he received an independent funding from the Volkswagen foundation and organized a Bioinformatics group at ICG. From 2000 to 2010, he has been the Senior Vice President Research & Development of BIOBASE GmbH, Wolfenbüttel, Germany.
The scientific career of Dr. Kel includes numerous research stays in the USA (e.g. 1993: Supercomputer Center, Tallahassee; 1997: University of Pennsylvania, Philadelphia; 1999, 2000: Cold Spring Harbor, NY), in Italy (1991, 1992: ITBA, Milan), and in Germany (1994, 1995, 1996, 1997-1998: GBF; 1997: MPI of Molecular Biology, Berlin).
The research experience of Dr. Kel in Bioinformatics totals more than 20 years. During his career, he has worked in almost all branches of current bioinformatics including: theoretical models of molecular genetic information systems, sequence analysis, gene recognition, promoter analysis and prediction, analysis of protein secondary structure, prediction of RNA secondary structure, theory of mutation and recombination process, molecular evolution, databases and gene expression studies.
Alexander Kel is the author of more than 90 scientific publications. He is also an author of several chapters in books on bioinformatics, tutorials and education materials.
|Prof. Vladimir Poroikov graduated from the Physical Faculty of the M.V. Lomonosov Moscow State University in 1974, and obtained his Ph.D. Degree in Biophysics from the Biological Faculty of this University in 1981. In 1995 he obtained D. Sci. Degree in Pharmacology from National Research Center for Biologically Active Compounds (NRC BAC), Staraya Kupavna (Moscow Region). Currently Vladimir Poroikov is the Head of Department for Bioinformatics and Laboratory for Structure-Function Based Drug Design of the Institute of Biomedical Chemistry of Rus. Acad. Med. Sci., Moscow, Russia. He is also appointed as a Professor of Medical & Biological Faculty of Russian State Medical University. Earlier, Vladimir Poroikov worked as the Head of Department of Drug Design and Marketing at the NRC BAC. He is a Member of Editorial Board of a few scientific journals including Biomedical Chemistry, Chemical & Pharmaceutical Journal, SAR & QSAR in Environmental Research; Chairman of the Russian Section of the Cheminformatics and QSAR Society; Member of the American Chemical Society and the International Society on Computational Biology; Member of Organizing Committees and/or invited speaker of more than 12 International conferences during the past 3 years; co-author of over 160 papers published in peer-reviewed journals and monographs and 12 non-open published reports in R&D of new pharmaceuticals. His scientific interests include bioinformatics, chemoinformatics, (Q)SAR, molecular modelling and computer-aided drug discovery.|
|Sergey Zhatchenko is an IT veteran with more than 15 years in software industry. For the last 10 years he is a co-founder and CEO of Development On The Edge – a software company specializing in development of sophisticated information systems using the revolutionary BeanExplorerTM technology.
Sergey started his career as software developer with banking and financial industry. Later he was engaged in managing positions with various consulting companies. Finally, he decided to start his own business venture – Development On the Edge – to pursue his vision of business automation processes.
Sergey Zhatchenko holds the degree of a MSc. in Computer Science (with honors) from Novosibirsk State Technical University.